Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate + fentanyl versus propofol + fentanyl for pediatric dental sedation
IRCT20230515058193N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of etomidate, propofol and fentanyl in anxiety disorder (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Sedative effect during dental treatment and Feasibility of dental treatment in anxious and uncooperative children. Started Aug 2024; status: completed.
02
Drugs
etomidatepropofolfentanyl
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20230515058193N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230515058193N1.